The main contraindications to the use of the COVID-19 vaccine "KoviVac", developed by scientists at the Center. Chumakov, there are complications for any previous vaccines, acute symptoms of acute respiratory viral infections, pregnancy, as well as exacerbation of chronic diseases. This is stated in the instructions for use of the drug.
“Contraindications: serious post-vaccination reaction (temperature above 40˚C, hyperemia or edema more than 8 cm in diameter) or complications to any previous vaccination in history; aggravated allergic history pregnancy and breastfeeding period,”the developers warned.
In addition, KoviVak is contraindicated for persons under 18 years of age. Temporary contraindications include acute febrile conditions, as well as infectious and non-infectious diseases. In this case, the vaccination should be done 2-4 weeks after recovery. In case of mild ARVI or acute intestinal infections, the vaccine can be done after the normalization of body temperature, writes RIA Novosti.
People who experience exacerbations of chronic diseases should be vaccinated during the period of remission. Patients with chronic diseases of the liver and kidneys, the central nervous system, severe diseases of the circulatory and cardiovascular systems, as well as the gastrointestinal tract and autoimmune diseases should be approached with caution.
The KoviVac vaccine is the third domestically produced vaccine against coronavirus. On Saturday, February 20, it became known about the registration of the drug by the Ministry of Health of the Russian Federation. The first 120 thousand doses of KoviVac will be launched into civilian circulation in mid-March.
